PortfoliosLab logoPortfoliosLab logo

ProShares UltraShort Nasdaq Biotechnology (BIS) belongs to the Leveraged Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with BIS. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to BIS

BIS charges 0.95% annually. There are 92 ETFs in the Leveraged Equities category with lower expense ratios, going as low as 0.35%.


Best Risk-Adjusted Alternatives to BIS

BIS has a PortfoliosLab risk / return rank of 0. There are 245 ETFs in the Leveraged Equities category with higher risk-adjusted ranks, going as high as 98.


Top Performing BIS Alternatives (YTD)

BIS is at -17.93% YTD. There are 217 ETFs in the Leveraged Equities category with higher YTD returns, going as high as 780.13%.


Lowest Volatility Alternatives to BIS

BIS has 40.51% 1-year volatility. There are 86 ETFs in the Leveraged Equities category with lower 1-year volatility, going as low as 4.83%.


Lowest Drawdown Alternatives to BIS

BIS has a 1-year max drawdown of -55.07%. There are 157 ETFs in the Leveraged Equities category with shallower 1-year drawdowns, going as shallow as -1.72%.


Other ETFs from ProShares

The 10 most viewed ProShares ETFs shown here include TQQQ, BITO, QLD and span 10 categories. AUM among these funds goes as high as $40B.


Often Compared With BIS

Investors most often compare BIS with BIB, RSPN, IBBQ. These 20 comparison targets span 10 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
ProShares Ultra Nasdaq BiotechnologyLeveraged Equities
80
12.50%
73.95MApr 2010BIS vs BIB
Invesco S&P 500® Equal Weight Industrials ETFIndustrials Equities, S&P 500, Equal Weight
34
9.36%
1.09BJan 2006BIS vs RSPN
Invesco Nasdaq Biotechnology ETFHealth & Biotech Equities
83
8.67%
68.94MJun 2021BIS vs IBBQ
AdvisorShares Ranger Equity Bear ETFInverse Equities
10
6.12%
67.03MJan 2011BIS vs HDGE
Innovator IBD 50 ETFLarge Cap Growth Equities
30
20.94%
89.40MApr 2015BIS vs FFTY
State Street Health Care Select Sector SPDR ETFHealth & Biotech Equities
32
-0.85%
38.47BDec 1998BIS vs XLV
Nasdaq, Inc.
34
-14.50%
BIS vs NDAQ
Invesco Dynamic Pharmaceuticals ETFHealth & Biotech Equities
85
9.74%
340.44MJun 2005BIS vs PJP
Global X DAX Germany ETFEurope Equities
11
-1.81%
248.64MOct 2014BIS vs DAX
Vanguard Information Technology ETFTechnology Equities
58
23.32%
170.10BMar 2004BIS vs VGT
Leverage Shares 2X Long CMG Daily ETFLeveraged Equities
-37.52%
1.31MNov 2025BIS vs CMGG
GraniteShares 2x Long VRT Daily ETFLeveraged Equities
83
187.83%
86.66MMar 2025BIS vs VRTL
Leverage Shares 2X Long PYPL Daily ETFLeveraged Equities
1
-56.83%
18.10MApr 2025BIS vs PYPG
Leverage Shares 2X Long XYZ Daily ETFLeveraged Equities
9
1.41%
2.95MApr 2025BIS vs XYZG
Leverage Shares 2X Long COST Daily ETFLeveraged Equities
15.84%
8.96MSep 2025BIS vs COTG
Direxion Daily GOOGL Bull 2X SharesLeveraged Equities
94
11.40%
1.24BSep 2022BIS vs GGLL
Leverage Shares 2X Long TSM Daily ETFLeveraged Equities
85
80.39%
33.08MJan 2025BIS vs TSMG
Leverage Shares 2X Long ARM Daily ETFLeveraged Equities
56
647.02%
229.25MJan 2025BIS vs ARMG
Direxion Daily South Korea Bull 3X SharesLeveraged Equities
93
285.56%
2.15BApr 2013BIS vs KORU
Direxion Daily MU Bull 2X SharesLeveraged Equities, Semiconductors6.59BOct 2024BIS vs MUU

Compare BIS with Any Fund or Stock

Compare BIS with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair BIS with funds that move differently

ProShares UltraShort Nasdaq Biotechnology alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to BIS.

Explore BIS Diversifiers